Show simple item record

An audit on virological efficacy of anti-retroviral therapy in a specialist infectious disease clinic.

dc.contributor.authorReyad, A
dc.contributor.authorWaldron, C
dc.contributor.authorCanning, R
dc.contributor.authorO'Shea, D
dc.contributor.authorCoakley, P
dc.contributor.authorMcConkey, S
dc.date.accessioned2011-04-06T14:02:54Z
dc.date.available2011-04-06T14:02:54Z
dc.date.issued2009-06
dc.identifier.citationAn audit on virological efficacy of anti-retroviral therapy in a specialist infectious disease clinic. 2009, 102 (6):186-8 Ir Med Jen
dc.identifier.issn0332-3102
dc.identifier.pmid19722358
dc.identifier.urihttp://hdl.handle.net/10147/127438
dc.description.abstractWe have assessed the efficacy of anti retroviral therapy (ART) using undetectable viral load (VL) (<50 RNA copies/ml) as a marker of virological success, in patients who have Human Immunodeficiency Virus (HIV) attending the Department of Infectious Disease. A cross-sectional review of patients' case notes was used to obtain their demographics and treatment details. 79% (253) of the hospital case notes of clinic population was available for analysis, which represents 90% of those receiving ART in the clinic. 166/253 of the cohort were receiving treatment at the time of this study and 95% (157/166) of these were on treatment for greater than 6 months. The total virological success rate is 93%, which is comparable to other centres and are as good as those from published clinical trials. 56% of those on therapy who have virological failure were Intravenous Drug Users (IVDUs). Case by case investigation for those with treatment failure is warranted.
dc.language.isoenen
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAnti-HIV Agents
dc.subject.meshCD4 Lymphocyte Count
dc.subject.meshCross-Sectional Studies
dc.subject.meshFemale
dc.subject.meshHIV Infections
dc.subject.meshHIV-1
dc.subject.meshHumans
dc.subject.meshInfectious Disease Medicine
dc.subject.meshIreland
dc.subject.meshMale
dc.subject.meshMedical Audit
dc.subject.meshMiddle Aged
dc.subject.meshRetrospective Studies
dc.subject.meshViral Load
dc.subject.meshYoung Adult
dc.titleAn audit on virological efficacy of anti-retroviral therapy in a specialist infectious disease clinic.en
dc.typeArticleen
dc.contributor.departmentDepartment of Infectious Disease, Beaumont Hospital, Beaumont, Dublin 9. A.I.Reyad@hotmail.comen
dc.identifier.journalIrish medical journalen
dc.description.provinceLeinster
html.description.abstractWe have assessed the efficacy of anti retroviral therapy (ART) using undetectable viral load (VL) (<50 RNA copies/ml) as a marker of virological success, in patients who have Human Immunodeficiency Virus (HIV) attending the Department of Infectious Disease. A cross-sectional review of patients' case notes was used to obtain their demographics and treatment details. 79% (253) of the hospital case notes of clinic population was available for analysis, which represents 90% of those receiving ART in the clinic. 166/253 of the cohort were receiving treatment at the time of this study and 95% (157/166) of these were on treatment for greater than 6 months. The total virological success rate is 93%, which is comparable to other centres and are as good as those from published clinical trials. 56% of those on therapy who have virological failure were Intravenous Drug Users (IVDUs). Case by case investigation for those with treatment failure is warranted.


This item appears in the following Collection(s)

Show simple item record